Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland

Journal of Neurology

Volumn 252, Issue 10, 2005, Pages 1245-1248

  McGuigan, Christopher ^a,b   Dunne, Ciaran ^c   Crowley, John ^c   Hagan, Richard ^c   Rooney, Genevieve ^c   Lawlor, Eimear ^c   Hutchinson, Michael ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b ST MARY S HOSPITAL   (United Kingdom)

^c National Blood Centre Ireland   (Ireland)

Author keywords

(Genetic) epidemiology; Epidemiology; Genetics of multiple sclerosis; MS

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GEOGRAPHY; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; IRELAND; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS; ODDS RATIO; PREVALENCE;

EID: 26644447610     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0850-8     Document Type: Article

References (18)

1. Al-Din ASN, al-Saffar M, Siboo, Behbehani K (1986) Association between HLA-D region epitopes and multiple sclerosis in Arabs. Tissue Antigens 27:196-200
2. Cullen CG, Middleton D, Savage DA, Hawkins S (1991) HLA DR and -DQ Genotyping in Multiple Sclerosis patients in Northern Ireland. Hum Immunol 30:1-6
3. Downie AW, Phadke JG (1984) The Chief Scientists reports: multiple sclerosis in north east Scotland. Health Bulletin (Edin) 42:151-156
4. Ebers GC, Sadovnick AD (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54:1-17
5. Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative study group. Nature 377:150-151
6. Epplen C, Jackel S, Santos EJ, et al. (1997) Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 41:341-352
7. GAMES and the Transatlantic Multiple Sclerosis Genetics Cooperative (2003) A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 143:39-46
8. Jerslid C, Fog T, Hansen GS, et al. (1973) Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 2:1221-1225
9. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
10. Marrosu MG, Murru MR, Costa G, et al. (1997) Multiple sclerosis in Sardinia is associated and linked with HLA-DR3 and -DR4. Am J Hum Gen 61:454-457
11. McDonnell GV, Mawhinney H, Graham CA, et al. (1999) A study of the HLA-DR region in clinical subtypes of multiple sclerosis and its influence on prognosis. J Neurol Sci 165:77-83
12. McGuigan C, McCarthy A, Quigley C, et al. (2004) Latitudinal variation in the prevalence of multiple sclerosis in Ireland: an effect of genetic diversity. J Neurol Neurosurg Psychiatry 75:572-576
13. Mumford CJ, Wood NW, Kellar-Wood HF, et al. (1994) The British Isles survey of multiple sclerosis in twins. Neurology 44:11-15
14. Poser C (1994) The dissemination of multiple sclerosis: a Viking saga? A historical essay. Ann Neurol 36:S231-S243
15. Poser CM, Paty DW, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
16. Sadovnick AD, Armstrong H, Rice G, et al. (1993) A population based study of multiple sclerosis in twins: update. Ann Neurol 33:281-285
17. Swingler RJ, Kirk PF, Darke C, Compston DAS (1987) HLA and multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 50:1153-1155
18. Willers C, Ebers G (2000) Susceptibility to multiple sclerosis: interplay between genes and environment. Curr Opin Neurol 13:241-247